董事会成员

Eric L. Sorkin
主席及行政总裁

Sorkin先生有25年战略性投资和业务发展经验。他与Immtech的关系从1998年投资於Immtech开始。在2000年，Sorkin先生成为该公司董事，最近被任命为董事会主席兼行政总裁。Sorkin先生在1982年在Dean Witter–现在是Morgan Stanley的子公司工作，自此开始在华尔街的职业生涯，六年内他从初级职位晋升为执行董事。他在公司处於专业人士的核心团体，将公司投资组合发展至总资产超过30亿美元。Sorkin先生负责投资选择、谈判、交易及财务组合、债务配售以及资产管理。Sorkin先生是20馀家投资资金总数达十亿美元以上的公共投资合作夥伴的高级职员。1993年，Sorkin先生创办了自己的投资公司，并开始在美国和中国进行私募基金投资。Sorkin先生从耶鲁大学获得经济学学士学位。

• Mr. Sorkin has been affiliated with Immtech since 1998, when he became an investor. In 2000, Mr. Sorkin became a director for the Company, and more recently was appointed Chairman of the Board and CEO. Mr. Sorkin began his career on Wall Street in 1982 working at Dean Witter, which is now a subsidiary of Morgan Stanley, and from an entry-level position, he was promoted to Managing Director within six years. He was among the core group of professionals at the firm, which developed the firm誷 investment portfolio with assets of over USD $3 billion. Corporations, banks and entities with which Mr. Sorkin worked on completed transactions included Aetna, International Paper, Continental Insurance, Barclays Banks, Chase Manhattan, Harvard University, Southern Bell, Cigna, the State of Wisconsin, AIG, Modern Woodman of America, Zurich American Life, and San Francisco City and County. Mr. Sorkin was responsible for investment selection, negotiations, transaction and financial structuring, debt placement, and asset management. Mr. Sorkin was Vice President, Owner, and/or Director of over 20 public investment partnerships with investment funds totaling over USD $1 billion. In 1993, Mr. Sorkin created his own investment firm and began making private equity investments in the U.S. and in China. Mr. Sorkin graduated Yale University with a B.A. in Economics.

Cecilia Chan
副主席

David Fleet
David Fleet Pharmaceutical Industry Consultancy Services 董事长
OnMedica Group Ltd. 非执行总监
IatRx Pharma 总监

Judy Lau
Convergent Business Group 主席
中国香港

Levi Hong Kaye Lee, M.D.
玛丽医院
中国香港

Donald F. Sinex
董事会董事
Devonwood, Inc.

使用条件 | 私隐条例
© 2008 Immtech. 版权所有